CTTN and neoplasm: Cortactin promotes cell motility and tumor metastasis via activation and stabilization of the Arp2/3 complex, which leads to the development of protrusive structures (invadopodia and lamellipodia) and subsequent degradation of the extracellular matrix (ECM) [21].